Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
Griñó
J M
JM
Department of Nephrology, University of Barcelona, Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.
Castelao
A M
AM
Serón
D
D
Gonzalez
C
C
Galceran
J M
JM
Gil-Vernet
S
S
Andrés
E
E
Bover
J
J
Torras
J
J
Alsina
J
J
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D013997:Time Factors
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D011241:Prednisone; D008775:Methylprednisolone